News
1d
Medical Device Network on MSNBD announces wearable injector trial for subcutaneous delivery of biologics
The prefilled, patient-ready-to-use system is said to support delivery of high-viscosity biologics of up to 50 centipoise.
Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...
BD has found a new home for its biosciences and diagnostics divisions at the lab equipment maker Waters Corporation, through ...
Waters and BD will merge biosciences and diagnostics in a $17.5B deal via Reverse Morris Trust, creating a life sciences ...
Becton Dickinson (BDX) announced the first pharma-sponsored combination product clinical trial using the BD Libertas Wearable Injector for ...
Franklin Lakes, New Jersey Thursday, July 24, 2025, 14:00 Hrs [IST] ...
The BD business will be spun off and merged with a Waters subsidiary. Waters shares were down about 11% in early trading ...
BD has picked a new executive to lead its planned connected care segment, as the company nears the conclusion of its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results